Brief: Enlivex Receives Notice Of Allowance For Japanese Patent Application Covering The Use Of Allocetra In Combination With Car-T Therapies
08/03/2021 13:22
March 8 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX RECEIVES NOTICE OF ALLOWANCE FOR JAPANESE PATENT
APPLICATION COVERING THE USE OF ALLOCETRA IN COMBINATION WITH
CAR-T THERAPIES
* ENLIVEX THERAPEUTICS LTD - EXPECTS THAT THIS NEW PATENT
WILL BE
ISSUED IN JAPAN IN Q2 OF 2021
Source text for Eikon: ID:nGNX2HMZSV
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment